-
公开(公告)号:DE69631609D1
公开(公告)日:2004-03-25
申请号:DE69631609
申请日:1996-10-17
Applicant: ABBOTT LAB
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulae (I); (II); (III) or (IV) wherein A, B, D and E, R , R and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of antibacterial infections with such compositions, and processes for the preparation of the compounds.
-
公开(公告)号:DE69631609T2
公开(公告)日:2005-01-05
申请号:DE69631609
申请日:1996-10-17
Applicant: ABBOTT LAB
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulae (I); (II); (III) or (IV) wherein A, B, D and E, R , R and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of antibacterial infections with such compositions, and processes for the preparation of the compounds.
-
公开(公告)号:DE69830739T2
公开(公告)日:2006-04-20
申请号:DE69830739
申请日:1998-10-29
Applicant: ABBOTT LAB
IPC: C07H17/08 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/04
Abstract: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
-
公开(公告)号:DE69830739D1
公开(公告)日:2005-08-04
申请号:DE69830739
申请日:1998-10-29
Applicant: ABBOTT LAB
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
-
-
-